BNY Mellon US Mid Cap Core Equity ETF (BKMC)
Performance
The fund's own total return, a year on average over the longer periods; volatility is the yearly standard deviation of its returns.
Volatility 13.4% over one year, 16.3% over three; Sharpe ratio over three years 0.68.
Largest components
| PTCPTC Inc | 0.62% | Technology | |
| THCTenet Healthcare Corporation | 0.62% | Healthcare | |
| ROKURoku Inc | 0.58% | Communication Services | |
| USFDUS Foods Holding Corp | 0.56% | Consumer Defensive | |
| GHGuardant Health Inc | 0.55% | Healthcare | |
| VTRSViatris Inc | 0.55% | Healthcare | |
| MTSIMACOM Technology Solutions Holdings Inc | 0.52% | Technology | |
| DTDynatrace Holdings LLC | 0.51% | Technology | |
| ITTITT Inc | 0.51% | Industrials | |
| SNASnap-On Inc | 0.51% | Industrials |
Sectors
Regions
Asset classes
About the fund
- Issuer
- BNY Mellon
- Since
- 2020-04-07
- Listed on
- NYSE ARCA
- ISIN
- US09661T2069
- Turnover
- 27% a year
Under normal circumstances, the fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of medium-capitalization U.S. companies, ETFs providing exposure to such securities, and derivatives with economic characteristics similar to such securities. The index is a free float market capitalization weighted index designed to measure the performance of 400 mid-capitalization companies listed on U.S. stock markets. It is non-diversified.
From the market data provider's fund data, read 2026-10-19. Returns are the fund's own; past returns say nothing certain about future ones. None of this is advice.